68Ga-Trivehexin PET/CT 在乳腺癌中检测小原发灶优于18F-FDG PET/CT
本文对比了68Ga-Trivehexin PET/CT与18F-FDG PET/CT在一名49岁乳腺癌女性患者中的显像表现。两种方法均检出左乳中央软组织肿块,但68Ga-Trivehexin PET/CT额外检出3个18F-FDG PET/CT未发现的微小病灶。作者认为68Ga-Trivehexin PET/CT对乳腺癌的检测效能可能优于18F-FDG PET/CT,有望作为替代显像剂。
要点
- 68Ga-Trivehexin PET/CT与18F-FDG PET/CT均检出左乳中央软组织肿块。
- 68Ga-Trivehexin PET/CT额外检出3个18F-FDG PET/CT未发现的微小病灶。
- 作者认为68Ga-Trivehexin PET/CT对乳腺癌检测效能可能优于18F-FDG PET/CT。
核心结论
- 作者认为68Ga-Trivehexin PET/CT对乳腺癌的检测效能可能优于18F-FDG PET/CT,有望作为替代显像剂。
研究设计与样本
- 本文为一名49岁乳腺癌女性患者的病例报告,对比68Ga-Trivehexin PET/CT与18F-FDG PET/CT显像。
主要发现
- 两种显像方法均检出左乳中央软组织肿块。
- 68Ga-Trivehexin PET/CT除检出大病灶外,还检出3个18F-FDG PET/CT未发现的微小病灶。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We compared 68 Ga-Trivehexin PET/CT imaging with 18 F-FDG in a 49-year-old woman diagnosed with breast cancer. While both imaging modalities detected a soft tissue mass in the central left breast, 68 Ga-Trivehexin PET/CT identified not only the large lesion but also 3 additional tiny foci that were undetected by 18 F-FDG PET/CT. Our report suggested that 68 Ga-Trivehexin PET/CT might offer superior detection efficacy for breast cancer compared with 18 F-FDG PET/CT, highlighting its potential as an alternative imaging agent.
引用
- Liu Z, Li C, Xiao Z, et al. 68 Ga-Trivehexin PET/CT Enhances Detection of Small Primary Lesions Than 18 F-FDG PET/CT in Breast Cancer. Clin Nucl Med. 2025. PMID: 40644590. doi:10.1097/RLU.0000000000006031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。